Abstract
In recent years, aortic stenosis and mitral regurgitation have stolen the limelight from other forms of valvular disease. However, treatment of aortic regurgitation (AR) has made solid advancements, of which the greatest have been the improved outcomes for aortic valvuloplasty, which has already become a practical option in a few institutions.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Boodhwani M, de Kerchove L, Glineur D, Poncelet A, Rubay J, Astarci P, et al. Repair-oriented classification of aortic insufficiency: impact on surgical techniques and clinical outcomes. J Thorac Cardiovasc Surg. 2009;137:286–94.
Puskas J, Gerdisch M, Nichols D, Quinn R, Anderson C, Rhenman B, et al., PROACT Investigators. Reduced anticoagulation after mechanical aortic valve replacement: interim results from the prospective randomized on-X valve anticoagulation clinical trial randomized Food and Drug Administration investigational device exemption trial. J Thorac Cardiovasc Surg. 2014;147:1202–10.
Eikelboom JW, Connolly SJ, Brueckmann M, Granger CB, Kappetein AP, Mack MJ, et al., RE-ALIGN Investigators. Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med. 2013;369:1206–14.
Isaacs AJ, Shuhaiber J, Salemi A, Isom OW, Sedrakyan A. National trends in utilization and in-hospital outcomes of mechanical versus bioprosthetic aortic valve replacements. J Thorac Cardiovasc Surg. 2015;149:1262–9.e3.
Chan V, Malas T, Lapierre H, Boodhwani M, Lam BK, Rubens FD, et al. Reoperation of left heart valve bioprostheses according to age at implantation. Circulation. 2011;124:S75–80.
Urso S, Calderón P, Sadaba R, Mahillo I, Tuñón J, Aldamiz G, et al. Patient-prosthesis mismatch in patients undergoing bioprosthetic aortic valve implantation increases risk of reoperation for structural valve deterioration. J Card Surg. 2014;29:439–44.
Johnston DR, Soltesz EG, Vakil N, Rajeswaran J, Roselli EE, Sabik JF 3rd, et al. Long-term durability of bioprosthetic aortic valves: implications from 12,569 implants. Ann Thorac Surg. 2015;99:1239–47.
McClure RS, McGurk S, Cevasco M, Maloney A, Gosev I, Wiegerinck EM, et al. Late outcomes comparison of nonelderly patients with stented bioprosthetic and mechanical valves in the aortic position: a propensity-matched analysis. J Thorac Cardiovasc Surg. 2014;148:1931–9.
Mérie C, Køber L, Skov Olsen P, Andersson C, Gislason G, Skov Jensen J, et al. Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding. JAMA. 2012;308:2118–25.
Berger PB, Vedamurthy D, Casale A, Sun H, Benoit C, Ferrari A, et al. The risk of thromboembolic complications without anticoagulation after surgical aortic valve replacement with a bioprosthesis. J Am Coll Cardiol. 2015;65:A2041. https://doi.org/10.1016/S0735-1097(15)62041-1.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Watanabe, H. (2019). Cardiologists’ Expectations of Aortic Valvuloplasty. In: Kunihara, T., Takanashi, S. (eds) Aortic Valve Preservation. Springer, Singapore. https://doi.org/10.1007/978-981-13-2068-2_40
Download citation
DOI: https://doi.org/10.1007/978-981-13-2068-2_40
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-2067-5
Online ISBN: 978-981-13-2068-2
eBook Packages: MedicineMedicine (R0)